NRx Pharmaceuticals Attracts Analyst Attention With Buy Rating and Ketamine Market Ambitions Ferraris Luce EV Enters Luxury Electric Segment Amid Market Uncertainties Bitcoins Evolution Signals a Paradigm Shift Beyond Pure Speculation Goldman Sachs and Societe Generale Lead Investors in Acquiring 13 Stake in Paytm for 963 Crore Fed Dissenters Voice Opposition to Rate Cut Hints in Latest Policy Statement UK Police to Assess Train Operators on Sexual Harassment Measures but No Penalties for NonCompliance PNBK Q1 2019 Earnings EPS Misses Estimates by Wide Margin Shares Decline DGXX Q3 2025 Earnings Loss Per Share of 003 as Company Navigates Challenging Environment AFB Q3 2024 Earnings Net Investment Income per Share Reported at 011 No Analyst Estimate Available POWL Q1 2026 Earnings EPS Misses Estimates Amidst Operational Headwinds Scholar Rock Q1 2026 Earnings WiderthanExpected Loss as Pipeline Development Continues Kayne Anderson Energy Infrastructure Fund KYN Edges Lower as It Tests Support Within Tight Trading Range Cellyan Biotechnology HKPD Holds Steady Near Support After Marginal Gains Rithm Acquisition Corp RAC Holds Steady Near Support A Period of Consolidation for the SPAC NovaBay Pharmaceuticals NBY Surges 226 Key Levels to Monitor Treasury Yields Edge Lower as Iran Peace Deal Optimism Tempers SafeHaven Demand Chinas CatandMouse Crypto Crackdown Middlemen Fuel Underground Trade Gokaldas Exports Reports 9 Sequential Revenue Growth in Q4 Amid Global Trade Challenges SpaceX Files for IPO Under Ticker SPCX Potentially Boosting Elon Musks Wealth to Trillionaire Status Wall Street Week Ahead Soaring Stocks May Face Turbulence as Earnings Season Winds Down and Bond Yields Rise Goldman Sachs PostEarnings Outlook Market Perception vs Financial Performance SpaceX IPO Plans Blockbuster Spending on Rockets and AI Signals Potential RecordBreaking Listing GD Q1 2026 Earnings Strong Earnings Beat Driven by Aerospace and Defense Momentum BioTechne TECH Q1 2026 Earnings EPS Falls Short of Estimates but Stock Rises CMPR Q1 2026 Earnings Massive EPS Beat Surprises Market IMPPP Q1 2026 Earnings Strong EPS Surprise of 644 Exceeds Expectations MFIC Q1 2026 Earnings EPS Beats Estimates Stock Dips TRMB Q1 2026 Earnings EPS Beats Estimates by 794 Stock Slips on Market Sentiment Inhibikase Therapeutics IKT Q1 2026 Earnings Narrowing Losses as Pipeline Progress Takes Center Stage Edgewise Therapeutics Inc EWTX Q1 2026 Earnings Narrowerthanexpected loss underscores disciplined RD execution